In 376 adults with symptomatic chronic subdural haematoma, adding middle meningeal artery embolisation with n-BCA to standard care cut residual/recurrent haematoma or surgery at 6 months (11.6% vs 22.1%; OR 0.53); adverse events 71.8% vs 65.3%.
RCTn = 376
Kellner et al. Middle Meningeal Artery Embolization With n-Butyl Cyanoacrylate in Patients With Chronic Subdural Hematoma: A Randomized Clinical Trial